Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 19Breast Neoplasms 15Prostatic Neoplasms 14Colorectal Neoplasms 14Hematopoietic and Lymphatic System Neoplasm 12Lung Neoplasms 10Ovarian Neoplasms 5Multiple Myeloma 5Hematologic Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Malignant Solid Neoplasm 4Hematopoietic and Lymphoid System Neoplasm 4Depression 4Uterine Cervical Neoplasms 3Neoplasm Metastasis 3Lymphoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Anxiety Disorders 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Urinary Bladder Neoplasms 2Triple Negative Breast Neoplasms 2Thyroid Cancer, Papillary 2Oropharyngeal Neoplasms 2Mouth Neoplasms 2Motor Activity 2Melanoma 2Malignant Female Reproductive System Neoplasm 2Leukemia 2

Interventions

Dexmedetomidine 5Saline Solution 4Haloperidol 4Sodium Chloride 3Propofol 2Lorazepam 2suvorexant 1remimazolam 1haloperidol decanoate 1flurbiprofen axetil 1dexamethasone 21-phosphate 1Vitamin E 1Surveys and Questionnaires 1Standard of Care 1Sevoflurane 1Practice Guidelines as Topic 1Olanzapine 1Midazolam 1Melatonin 1Interviews as Topic 1Injections 1Inhalation 1Ibuprofen 1Donepezil 1Dexamethasone 1Chlorpromazine 1Anesthesia, Spinal 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Delirium × Interviews as Topic × Clear all
NCT06834386 2025-05-01

Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients

Mayo Clinic

Phase 4 Withdrawn

Delirium, Sleep Initiation and Maintenance Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡